leuprolide acetate
- Product NDC
- 0121-2106
- Requested package NDC
- 0121-2106-02
- 11-digit product format
- 001212106
- Labeler code
- 0121
- Product ID
- 0121-2106_b1a3e37b-0513-40cc-ab82-a6ec15dc533c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- leuprolide acetate
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Application
- ANDA217957
- Marketing category
- ANDA
- Marketing start
- 2025-02-01
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217957-001 | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217957-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | 2680178bc6a6… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | d8e5a09893c0… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217957-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2024-10-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217957-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A217957-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217957-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217957-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217957-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217957-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217957-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217957-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217957-001 | AP | 1 | 2680178bc6a6… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217957-001 | AP | 1 | d8e5a09893c0… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217957-001 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- leuprolide acetate
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 19be0b7f-e68a-4547-9e49-b51b12821907 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-1053-02 | leuprolide acetate | 2.8 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 2.8 mL | 5 mg in 1mL | 4 |
| 0121-1053-02 | leuprolide acetate | 1 in 1 CARTON | INJECTION, SOLUTION | 5 mg in 1mL | 4 | |
| 0121-2105-01 | leuprolide acetate | 1 mL in 1 PACKET | SWAB | 28 mL | 0.7 mL in 1mL | 4 |
| 0121-2106-02 | leuprolide acetate | 1 in 1 CARTON | KIT | 1 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-2106-02 | EA - Each | 0121-2106 | d7be06c2-7ade-49aa-98b0-ef95ef0445a6 | 1 | 2025-03-04 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| leuprolide acetate | LEUPROLIDE ACETATE | UBI Pharma Inc. | cd46628f-055f-4da9-8c38-fa69af34eb4d | 2026-03-29 | Warnings, Adverse reactions | 217957 ANDA217957 |
| leuprolide acetate | LEUPROLIDE ACETATE | PAI Holdings, LLC dba PAI Pharma | 19be0b7f-e68a-4547-9e49-b51b12821907 | 2026-01-16 | Warnings, Adverse reactions | 217957 ANDA217957 0121-2106-02 0121-2106 00121210602 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 797544 | isopropyl alcohol 70 % Medicated Pad | PSN | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
| 545835 | leuprolide acetate 1 MG/0.2 ML (5 MG/ML) Injectable Solution | PSN | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
| 797544 | isopropyl alcohol 0.7 ML/ML Medicated Pad | SCD | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
| 545835 | leuprolide acetate 5 MG/ML Injectable Solution | SCD | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
| 797544 | isopropyl alcohol 70 % Medicated Pad | SY | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
| 797544 | isopropyl alcohol 70 % Topical Cloth | SY | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
| 797544 | isopropyl alcohol 70 % Topical Swab | SY | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
| 545835 | leuprolide acetate 1 MG per 0.2 ML Injectable Solution | SY | 19be0b7f-e68a-4547-9e49-b51b12821907 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0121-2106-02 | 00121210602 | 1 KIT in 1 CARTON (0121-2106-02) * 1 VIAL, MULTI-DOSE in 1 CARTON (0121-1053-02) / 2.8 mL in 1 VIAL, MULTI-DOSE * 1 mL in 1 PACKET (0121-2105-01) | 1 kit | 2025-02-01 | No | No | Current |